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Human al-acid glycoprotein (orosomucoid)  (o~I-AG)  1  constitutes the main component of 
the seromucoid fraction of human plasma. It belongs to the acute phase proteins, which 
increase under conditions such as inflammation, pregnancy, and cancer (1, 2). al-AG has 
previously been found to be synthesized in liver (3), and after removal of terminal sialic 
acids,  it  is cleared from the circulation by binding to a  receptor protein on liver cell 
plasma membranes (4). 
The structure of al-AG is well known. It is composed of a single polypeptide chain and 
contains 245% carbohydrate including a large amount of sialic acid.  The carbohydrate is 
located in the first half of the peptide chain linked to asparagine residues (5, 6). 
The function of al-AG is unclear.  However, Schmid et al.  (5) and Ikenaka et al.  (7) 
and reported that the amino acid sequence of the protein shows a significant homology 
with human IgG. This finding and the striking increase in inflammatory and lymphopro- 
liferative disorders made us consider the possibility that leukocytes could be directly 
involved in the synthesis and release of a~-AG. 
We report here the presence of a  membrane form of al-AG, with an apparent 
tool wt of 52,000, on normal human lymphocytes, granulocytes, and monocytes. 
By the use of internal labeling with [3H]leucine in vitro, we demonstrate that 
the membrane protein is synthesized by lymphocytes. It is apparently subse- 
quently cleaved and released as the soluble serum form with the normal tool wt 
of 41,000. 
Materials and Methods 
Isolation of az-AG,  aI-AG was  isolated  from the  urine  of patients  with  acute  infectious 
mononucleosis by modifications of previously  published  methods  (8).  6 liters  of urine  were 
collected, dialyzed against tap water overnight, and lyophilized. The powder was dissolved in 0.02 
M sodium phosphate, pH 7.2, and applied to a 50-ml column of DEAE-cellulose made in the same 
buffer. After washing, a linear 200-ml gradient of 0.02 M sodium phosphate (200 ml of 1 M NaC1, 
0.02 M sodium phosphate) was applied. The a~-AG-containing  fractions, which were identified by 
polyacrylamide slab gel electrophoresis, eluted with an NaC1 concentration of 0.05-0.15 M. These 
were combined, dialyzed against  water,  and lyophilized. The powder was dissolved in 95 ml of 
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H20, and 5 ml of i  M sodium acetate was added.  After addition of ammonium sulfate to a final 
concentration of 2.73 M, the mixture was left at 4°C for 16 h. ARer centrifugation at 12,500 rpm in 
a  Sorvall SS-34 rotor for 15 vain,  the supernate  was recovered. The pH of the supernate  was 
adjusted to 4.9 with 2 N HCI, and this was left again at 4°C for 16 h. After centrifugation, the pH 
of the supernate was adjusted to 3.7 with 2 N HC1, and the sample was left at 4°C for 16 h. After 
centrifugation,  the  supernate  was removed and  the  sediment was dissolved in  HsO,  dialyzed 
against H20,  and lyophilized. The sample was then passed through a 15-ml column of concana- 
valin A-Sepharose 4B  (Pharmacia  Fine Chemicals, Uppsala,  Sweden) in 0.15 M NaC1-0.01 M 
sodium  phosphate,  pH  7.4  (PBS),  and  after  washing  it  was  eluted  with  0.1  M  a-methyl 
mannopyranoside (Calbiochem, San Diego, Calif.). The peak fractions eluted with the sugar were 
pooled,  dialyzed against HsO, and lyophilized. This sample was then passed over an  Ultrogel 
AcA54  column  (LKB  Produkter,  Stockholm,  Sweden)  in  PBS,  and  the  peak  fractions  were 
combined, dialyzed against H20, and lyophilized. The final yield of purified protein was 33 rag. 
Isolation and Cultivation of Human Leukocytes.  The following main populations of blood cells 
were isolated: granulocytes, monocytes, platelets, T lymphocytes, and B lymphocytes. They were 
isolated from buffy coats supplied by the Finnish Red Cross Blood Transfusion Service, Helsinki, 
Finland. The platelets and mononuclear cells were separated from the granulocytes and erythro- 
cytes by a one-step Ficoll-Isepaque (density 1.077; Pharmacia Fine Chemicals) gradient centrifu- 
gation (9), at 400g for 40 rain. 
Purification  of Granulocytes.  The pellets obtained after Ficoll-Isopaque centrifugation that 
contained erythrocytes and granulocytes were suspended in 20 ml of PBS.  10 ml of 0.15 M NaCl 
containing 6% dextran (Mecrodex 6%; Leiras, Turku, Finland) was added, and the cell suspension 
was kept for 40 rain at 37°C, The granulocyte-rich buffy coat was then collected, and contaminat- 
ing erythrocytes were lysed by incubation in 0.017 M Tris-0.84% NH4C1, pH 7.45. The leukocytes 
were then washed three times with PBS. This procedure yielded a cell population which contained 
>97% granulocytes as judged from May-Gruenwald-Giemsa (MGG)-stained  cytocentrifuged cell 
smears. The cell viability was close to 100%, as seen in the trypan blue exclusion test. 
Purification of Platelets.  The platelets were purified from the cell population obtained from 
the interphase after Ficell-Isopaque centrifugation. This cell population was suspended in PBS, 
centrifuged for 10 rain at 200g, and the platelet-rich supernate was recovered. This procedure was 
repeated once, and the platelets were then pelleted at 400 g for 20 rain. The purity of the platelet 
preparation approached 100%, and the contamination by other blood cells was always <0.002%. 
Purification  of Monocytes.  The blood  monocytes were  separated  from  the  cell population 
recovered at the interphase after Ficoll-Isopaque centrifugation. The platelets were depleted by 
three washes with PBS at 200 g for 10 rain. The mononuclear cell population was mixed at a ratio 
of 1:50 with 2-amino ethylisothiouronium bromide (AET)  (Sigma Chemical Co.,  St. Louis, Mo.) 
treated sheep erythrecytes (SRBC)  (10). After incubation for 15 min at 37°C, the mixture was 
centrifuged for 10 rain at 200 g and the T cells were allowed to rosette with the AET-SRBC for 1 h 
on ice. The pellet was then gently suspended in cold PBS containing 30% newborn calf serum, and 
the resette-forming cells were separated  from the non-rosette-forming cells by Ficoll-Isopaque 
centrifugation. The cell population recovered from the interphase mainly contained monocytes 
and non-T lymphocytes. The rnonocytes  were then purified from the contaminating lymphecytes 
by a 1-g velocity sedimentation (11). ARer sedimentation for 4 h at 4°C, the gradient was drained 
into 20-ml fractions, and the cell content of each fraction was analyzed from MGG-stained smears. 
The early fractions which contained mainly monocytes were pooled.  The cell preparation thus 
obtained contained 90-95% monocytes, as judged by  conventional morphological criteria.  The 
viability always exceeded 98%. Slight contamination was caused  by occasional lymphoblasts, 
myeloid precursor cells,  and some granulocytes. 
Purification  of  T lymphocytes.  The platelet-depleted mononuclear cell  population recovered 
from the Ficoll-lsopaque centrifugation was passed over a human  Ig-rabbit  anti-human-lg 
column as described by Wigzell et al. (12).  The column-passed lymphocyte population contained 
< 1% surface immunoglobulin-bearing cells,  as  judged by staining with fluorescein  isothiocyanate 
(FITC)-conjugated polyvalent sheep anti-human imrnunoglobulin obtained from Professor Astrid 
Fagraeus, State Bacteriology Laboratory, Stockholm, Sweden. The viability  of  the T-cell  popula- 
tion  was always >98%, and >95% of  the cells  formed rosettes  with AET-SRBC. 
Purification  ofB Lymphocytes.  The mononuclear cells  obtained after  Ficoll-lsopaque  centrif- 
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plasma. Carbonyl iron was added and the suspension was incubated for 1 h at 37°C. The majority 
of the phagocytic cells was then removed with a magnet. The phagocyte-depleted cell population 
was  allowed  to  rosette  with  AET-SRBC  as  described  above.  The  T  cells  were  depleted  by 
centrifugation of the rosette-forming cell-containing cell suspensions  on a  FicoU-Isopaque gra- 
dient.  The non-T lymphocytes recovered from the interphase were further purified by velocity 
sedimentation  as  described  above.  The  later  fractions  obtained  after  sedimentation  for  4  h 
contained mainly small lymphocytes, as judged from MGG-smears.  These fractions were pooled 
and  the  cell population  thus  obtained  was  contaminated  by  <3%  nonlymphocytic cells.  This 
lymphocyte suspension was further fractionated over an Ig-anti-Ig column at 4°C to minimize Fc 
binding. The lymphocytes retained by the column were mechanically eluted by shaking the glass 
beads in PBS.  86% of the eluted lymphocytes stained positively for surface Ig, and  <2% bound 
AET-SRBC. This preparation was designated B lymphocytes. 
Establishment of Continuous B Lymphoblastoid Cell Lines (LBL) from Peripheral Blood.  LBL 
were established by cultivation of T-lymphocyte-depleted blood leukocytes from different patients 
with  acute  infectious  mononucleosis  (13). The  cell  lines  studied  in  this  work  were  grown 
continuously for more than 4 mo before use in RPMI-1640 medium supplemented with 10% calf 
seriLEa. 
Mixed Lymphocyte Culture (MLC).  Human blood T lymphocytes were purified and cultivated 
in RPMI-1640 medium supplemented with fetal calf serum or rabbit serum with mitomycin C (30 
~g/ml)  treated  allogeneic leukocytes at  an  initial  density  of 10  e respender  cells and  2  x  10  e 
stimulator cells/ml. 
Labeling of Allogen-Activated T Lymphocytes with [3H]Leucine.  MLC cells obtained after 5 
days in culture were washed in Dulbecoo's PBS and suspended in 15 ml of leucine and serum-free 
Eagle's minimal essential medium. To this was added 1.5 mCi [SH]lL-leucine (58 Ci/mmole; The 
Radiochemical Centre, Amersham, England) and the cells were incubated at 37°C for 16 h. The 
cells were then  pelleted by centrifugation  and  the  medium  was  recovered.  The  medium  was 
extensively dialyzed against  H20 and  lyophilized.  It was  then dissolved in  5  ml of PBS and 
centrifuged at  100,000 g  for 60  min in  a  Beckman  L2-50  centrifuge,  and  the supernates  were 
recovered. The cells were washed three times in PBS and lysed in PBS containing 1% Triton X- 
100, 2 mM phenyl methyl sulfonyl fluoride (Sigma Chemical Co.),  1% ethanol (buffer A). ARer 
centrifugation  at  100,000 g  for 60  min,  the supernate  was recovered.  For subsequent  immune 
precipitations, beth the growth medium and the cell extract were passed through 2-ml columns of 
Lens  culinaris-Sepharose,  and  the  absorbed  glycoproteins  were  eluted  with  0.1  M  s-methyl 
mannoside in buffer A. Lens culinaris beans were obtained from Dr. M. J. Crumpton,  Medical 
Research Council, Mill Hill, England,  and the lectins were purified by affinity chromatography 
on Sephadex G-50 (14) and coupled to Sepharose 4B (Pharmacia Fine Chemicals) by CNBr activa- 
tion (15).  Aliquots of the fractions were counted for radioactivity in a  WalIac-LKB 81000 liquid 
scintillation counter (16). The radioactive fractions obtained after elution with the sugar hapten 
were pooled and used for immunoprecipitations. 
Preparation ofc~l-AG Antiserum.  Rabbits were injected three times at 2-wk intervals with 0.5 
mg of a1-AG boiled in 1% sodium dedecyl sulfate (SDS), emulsified in Freund's adjuvant (Difco 
Laboratories, Detroit, Mich.), and bled 10 days after the last injection. 
Surface Labeling of Cells.  Cells were labeled with 3H by treatment with neuraminidase and 
galactose oxidase followed by NaB3H4  (16). The labeling conditions have been described in detail 
previously  (17).  The Vibrio cholerae neuraminidase  (500  U/ml; Behring-Werke  AG,  Marburg- 
Lahn, W.  Germany) and galactose oxidase (Kabi AB, Stockholm, Sweden) preparations did not 
contain proteolytic activity when assayed as described (16).  NaB3H4  (26 Ci/mmol) was obtained 
from The Radiochemical Centre. After labeling, the cells were dissolved in buffer A and centri- 
fuged at 10,000 g  for 15 min, and the supernates were recovered. 
Chemical Determinations.  Protein was determined according to Lowry et al. (18), with bovine 
serum albumin used as a  standard.  Amino acid analysis was performed with a  Beckman 120 C 
amino acid analyzer (Beckman Instruments,  Inc., Fullerton, Calif.) after hydrolysis in 6 N  HCI 
under  vacuum  at  110°C  for 22  h.  No correction was made for the destruction  of amino acids. 
Methionine and 1/2 cystine were determined after performic acid oxidation (19). Sialic acids were 
determined as described (20) with N-acetyl neuraminic acid (Sigma Chemical Co.) as a standard. 
Amino sugars were quantitated  by the Elson-Morgan reaction  (21),  and  the proportions of N- 
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analyzer (22).  Neutral sugars were determined after hydrolysis in 4 N H2SO4 at 100°C for 4 h as 
alditol acetates (23). 
Labeling of Cell Culture Medium and Purified a1-AG with 12~I.  MLCs carried on for 5 days in 
RPMI-1640 culture medium supplemented with 1% rabbit preimmunization serum were done as 
described above. The cells were pelleted by centrifugation, and the supernate was centrifuged at 
100,000 g  for 60 rain. After dialysis against H20 at 4°C for 24 h, 10/tl of the medium and 10 ~g of 
purified urinary  al-AG were iodinated by the chloramine-T method (24) using 0.5 mCi carrier- 
free  125I (Amersham  Corp.).  Fractions  were  collected  after  passing  through  a  0.5  ×  10-cm 
Sephadex G-25 column made in PBS and counted in a WalIac-LKB 80000 gamma sample counter. 
Immunoprecipitations  Using  Protein  A  Containing  Staphylococcus  aureus  (Strain  Cowan 
I).  Immunoprecipitations were made from Triton X-100 extracts of [~H]leucine-labeled cells or 
[3H]leucine-labeled  culture  medium  which  were  eluted  with  sugar  from  the  Lens  culinaris 
columns.  Immunoprecipitations  were also done directly from Triton X-100  extracts of surface- 
labeled cells and ~2~I-labeled culture medium. The samples were pretreated with 5 ~g mouse IgG 
and 5 pl rabbit anti-mouse IgG (prepared by standard techniques) for 1 h at 0°C. Then, 100 pl of 
a  10% suspension ofS. aureus Cowan I strain, obtained from Dr. P. Landwall of the Karolinska 
Institute, Stockholm, Sweden (25) was added, and the samples were further incubated at 0°C for 
60 rain. 100/~1 of the staphylococcal suspension bound IgG from 6/~1 of rabbit serum. The tubes 
were then centrifuged at 3,000 g  for 10 rain in a table centrifuge at 4°C, and the supernates were 
recovered.  To  identical  aliquots  of this  supernate  were  added  either  5  /zl rabbit  anti-al-AG 
antiserum, or 5/~l rabbit preimmunization serum, and the tubes were incubated at 0°C for 2 h. 
Then, 200 ~1 of the staphylococcal suspension was added, and the incubation was continued at 0°C 
for I  h. The staphylococci were then washed three times by centrifugation in 0.15 M NaC1, 0.05% 
Triton X-100, 5 mM EDTA, 0.02% sodium azide, pH 7.4, and the absorbed antigens were eluted by 
boiling  for  2  rain  in  1%  SDS.  The  staphylococci  were  pelleted  by  centrifugation,  and  the 
supernates were recovered and used for pelyacrylamide gel electrophoresis. 
Radioimmunoassay of a~-A  G from Supernates of Cell Cultures.  One of the lymphoblastoid B- 
cell lines was cultured at an initial cell density of 5 x  105 cells/ml in RPMI-1640 culture medium 
containing 10% fetal calf serum (Flow Laboratories, Glasgow, Scotland). At indicated times, 1.5- 
ml samples were taken, the cell number was counted, and 0.5-ml aliquots of the supernates were 
used for radioimmunoassay. 
A radioimmunoassay standard curve was made by using 0.00001-10  #ag of purified a~-AG in 0.5 
ml of the same fresh cell culture medium.  10 ~1 of rabbit preimmunization serum was added as 
carrier,  and the samples were incubated with ---- 30,000  cpm of ~2SI-labeled a~-AG and 0.1  /zl of 
rabbit anti-al-AG antiserum for 16 h at 4°C. The antiserum was calibrated to bind --- 30% oftbe 
total radioactivity. Then 100/zl of sheep anti-rabbit IgG antiserum was added,  and after 1 h  at 
4°C, the samples were centrifuged and the pellets were counted for radioactivity. The test samples 
were made in the same way, except that the purified aI-AG was omitted. The standard curve was 
linear for 0.0005-0.5/zg of a~-AG. 
Cleavage of  Proteins with Cyanogen Bromide (CNBr).  12SI-labeled purified a1-AG and labeled 
proteins eluted from cylindrical polyacrylamide gels were cleaved by treatment  with CNBr in 
70% formic acid for 24 h at room temperature (26). ARer dilution with 20 vol of H20, the samples 
were lyophilized and run on cylindrical polyacrylamide gels. 
Polyacrylamide  Gel  Electrophoresis.  Slab  and  cylindrical  polyacrylamide  gels  were  run 
according to Laemmli (27) in the presence of SDS with an acrylamide concentration of 8%.  Slab 
gels were stained with Coomassie brilliant blue according to Weber and Osborn (28). Cylindrical 
gels were sliced and counted (16).  Slab gels were treated for fluorography (29) and the gels were 
vacuum-dried and covered with Kodak RP X-Omat film (Eastman Kodak Co., Rochester, N.Y.) 
and exposed for 1-14 days at -70°C. The films were photographed and scanned with a Joyco-Loebl 
Chromoscan  (Joyce,  Loebl  and  Co.,  Ltd.,  Gateshead-on-Tyne,  England).  ~4C-labeled  standard 
proteins were prepared as described (30). 
Indirect Immunofluorescence.  To exclude nonspecific IgG binding to  Fc receptors,  F(AB)2 
fragments were prepared from anti-a~-AG anti-serum. 20 mg of IgG was digested with 0.5 mg of 
porcine pepsin (Schwarz/Mann Div. Becton, Dickinson & Co., Orangoburg, N.Y.) for 16 h at 37°C 
in 0.1 M sodium acetate buffer, pH 4.5, and the F(AB)2 fragments were isolated by gel filtration 
on Ultrogel AcA34 (LKB Produkter).  The F(AB)2 preparation appeared pure on pelyacrylamide 
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Fro. i.  Polyacrylamide gel  electrophoresis  of  purified  aI-AG. (A),  50  ~tg  of  purified  aI-AG 
was run on a polyacrylarnide  slab  gel in  the presence of  SDS and 2-mercaptoethanol  and 
stained  with  Coomassie brilliant  blue.  (B),  standard proteins:  TR, transferrin;  HA, human 
albumin; OA, ovalbumin. 
Cells  were  washed and  suspended in  i00/~I  of  ice-cold  PBS containing 20%  fetal  calf  serum. I00 
~g  anti-a1-AG F(AB)2, 10 ~I  anti-a1-AG antiserum or  10  ~l  preimmunization serum were added. 
After 30 rain  on ice,  the cells  were washed twice with 10  ml of  cold  fetal  calf  serum in  PBS and 
suspended in  20  ~l  of  1:20  diluted  FITC-conjugated IgG (1  mg/ml) isolated  from sheep  anti-rabbit 
IgG antiserum. After 20-30  min on  ice,  the  cells  were washed and  examined in  a Zeiss  Universal 
fluorescence  microscope (Carl  Zeiss,  Inc.,  New York) equipped with  epi-illuminater  Ill  RS and a 
high  pressure mercury lamp (200  W). For  capping  experiments, the  FITC-stained  cells  were incu- 
bated at  37°C. 
Results 
Purity,  Amino  Acid  and  Carbohydrate  Compositions  of Urinary  aI-AG. 
When aI-AG was isolated from urine and analyzed by slab polyacrylamide gel 
electrophoresis, only one band was obtained with an apparent mol wt of 41,000 
(Fig. 1). Our antiserum gave a single precipitation line of normal human serum 
on immunoelectrophoresis, and the same result was obtained with a commer- 
cially available anti-al-AG antiserum (Behringwerke). 
Table I shows the amino acid content and the carbohydrate composition of  the 
purified  urinary  protein.  The  amino  acid  composition  is  identical  to  that 
reported by other groups for a~-AG. 
Indirect Immunofluorescence  with Anti-al-AG Antiserum.  Isolated T and B 
lymphocytes, monocytes, and granulocytes showed a  slightly granular mem- 
brane fluorescence pattern after staining with rabbit anti-a~-AG F(AB)2  and 
FITC-conjugated sheep anti-rabbit  IgG.  To exclude the possibility of aI-AG 
adsorption from human serum,  four lymphoblastoid cell lines cultivated for 512  LEUKOCYTE  ~I-ACID  GLYCOPROTEIN 
TABLE I 
Amino Acid and Carbohydrate Compositions of al-Acid Glycoprotein  * 
Amino acids  Present  study* 
Calculated from 
amino acid  sequence 
(5) 
Lys  13.6 _+ 0.2  12.8 
His  3.1 -+ 0.0  3.0 
Arg  8.0  _  0.4  9.5 
Asx  20.3 _+ 0.4  20.6 
Thr  14.5 -  0.4  14.5 
Ser  6.7 _ 0.5  7.3 
Glx  33.0 _+ 0.8  29.5 
Pro  9.4 _+ 0.6  7.0 
Gly  7.7 +_ 0.6  7.3 
Ala  9.0 -+ 0.4  9.8 
•  Val  9.2 _+ 0.5  8.6 
Ile  9.2 -+ 0.2  9.0 
Leu  14.9 -+ 0.1  14.5 
Tyr  9.7 -+ 0.2  10.8 
Phe  9.4 -+ 0.1  8.8 
1/2 cys§  4.1 -+ 0.2  4.0 
Met§  0.9 -+ 0.0  1.3 
Trp  n.d.  3.0 
Carbohydrates  II 
N-acetyl neuraminic acid  14.3 
N-acetyl glucosamine  17.5 
N-acetyl galactosamine  0 
Fucose  7.2 
Mannose  19.1 
Galactese  27.2 
* mol/mol, assuming a mol  wt  of  41,000. 
* Mean of  four  determinations _+  standard  deviations. 
§ Determined  after  performic acid  oxidation. 
II Mean of  two  determinations. 
several  months in the  absence of human serum were also studied.  All of the 
four cell lines had a  clear membrane fluorescence, which showed redistribution 
or capping after  incubation at  37°C  (Fig.  2).  No fluorescence was detected  in 
cells treated with preimmunization rabbit serum. 
Surface Labeling ofLeukocytes.  T and B lymphocytes, granulocytes, mono- 
cytes  and  MLC  lymphoblasts  were  labeled  with  3H  after  treatment  with 
neuraminidase and galactose oxidase followed by NaB3H4, and then run on slab 
gels and exposed for fluorography. The cells contain a  large number of labeled 
characteristic surface proteins. The GP52 region is weakly labeled in all resting 
cells, and this protein is evidently a  minor component. Immunoprecipitation of 
surface-labeled T  lymphoblasts from MLC with anti-a~-AG anti-serum showed 
one band with an apparent mol wt of 52,000 (Fig. 3, column G). 
Immunoprecipitations of [3H]leucine-labeled cells and culture  medium with 
anti-al-AG antiserum. 
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FIG.  2.  Indirect immunofluorescence of cells of a lymphoblastoid line treated with rabbit 
anti-al-AG F(AB)2 and FITC-conjugated sheep anti-rabbit IgG. (a), Cells were incubated 
at 0°C; (b), redistribution of the fluorescence after incubation for 30 rain at 37°C. 
FIG.  3.  Polyacrylamide gel  electrophoresis patterns  of surface-labeled leukocytes and 
leukocyte  antigen  precipitated  with  anti-al-AG antiserum.  (A),  14C-labeled  standard 
proteins: TH, thyroglobulin; TR,  transferrin; HA, human albumin; OA, ovalbumin; HB, 
hemoglobin.  (B),  T  lymphocytes; (C),  B  lymphocytes; (D),  granulocytes; (E),  monocytes; 
(F), MLC  lymphoblasts; (G), pattern of immunoprecipitation from surface-labeled MLC 
blasts with anti-al-AG antiserum; (H), control with preimmunization serum. 514  LEUKOCYTE  OII-ACID GLYCOPROTEIN 
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Fro.  4.  Scanning patterns of immunoprecipitates obtained with anti-al-AG antiserum 
from  [3H]leucine-labeled MLC  lymphoblasts and culture medium separated by slab gel 
electrophoresis and visualized by fluorography. (A), from MLC lymphoblasts with anti-a~- 
AG antiserum; (B), from MLC lymphoblasts with preimmunization serum; (C), from MLC 
culture medium with anti-al-AG antiserum; (D), from MLC culture medium with preim- 
munization serum. Or, origin. 
react with anti-al-AG antiserum are synthesized by lymphocytes, Triton X-100 
extracts from MLC blasts labeled in culture with [3H]leucine and medium from 
the same cultures were treated with anti-al-AG antiserum or preimmunization 
serum  and  staphylococci,  eluted,  and  run  on  polyacrylamide  gels.  Fig.  4  A 
shows the scanning pattern of the immunoprecipitated antigen from cells. The 
apparent mol wt was 52,000. No radioactive band was obtained with preimmu- 
nization  serum  (Fig.  4 B).  When  the  cell  culture  medium  was  treated  with 
antiserum  and staphylococci, eluted,  run on gels and scanned,  the pattern  of 
Fig. 4 C was obtained. The apparent mol wt of the major peak was 41,000. Again 
no labeled protein was precipitated with preimvhunization serum (Fig. 4 D). 
Immunoprecipitations  of  Surface-Labeled Leukocytes.  Triton X-100 extracts 
from surface-labeled MLC blasts were precipitated with anti-al-AG antiserum 
and  staphylococci and  analyzed on cylindrical  gels.  Two peaks were obtained 
with apparent  mol wt of 52,000 and 41,000  (Fig.  5A).  The size of the smaller 
peak varied in different preparations.  No peaks were obtained with preimmu- 
nization serum (Fig. 5 B). Similar patterns were obtained with labeled granulo- 
cytes (Figs.  5 C  and  D).  Monocytes showed one major peak with  a  mol wt of 
52,000  (Figs.  5E  and  F).  No detectable  amounts  of labeled protein  could be 
precipitated  from  surface-labeled  resting  T  and  B  lymphocytes,  platelets,  or 
erythrocytes. 
Immunoprecipitation  of 125I-labeled Cell Culture  Medium with Anti-al-AG 
Antiserum.  To characterize the shedded antigen found in culture medium, an 
MLC was set up in RPMI-1640 containing rabbit preimmunization  serum, the CARL  G.  GAHMBERG  AND  LEIF  C.  ANDERSSON  515 
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FIG. 5.  Cylindrical polyacrylamide gel patterns of  radioactive  antigens precipitated  with 
anti-a1-AG antiserum from surface-labeled leukocytes. (A), MLC  blasts with anti-a~-AG 
antiserum;  (B),  MLC  blasts  with preimmunization serum; (C),  granulocytes with anti-al- 
AG antiserum;  (D),  granulocytes with preimmunization serum; (E),  monocytes with anti- 
a~-AG antiserum; (F),  monocytes with preimmunization serum. C and D were passed over 
a Lens culinaris  column and eluted with a-methyl mannoside before  immune precipitation. 
This procedure removed the nonspecific material of  low molecular weight running in the 
front. BPB, position  of  bromphenol blue marker dye. 
medium was labeled with 125I,  and immunoprecipitated with anti-a~-AG anti- 
serum. The pattern of Fig. 6 was obtained with the major peak corresponding to 
a  mol wt of 41,000. 
Accumulation of arAG in the Medium of  Lymphoid Cell Cultures.  The rate 
of accumulation of al-AG in the culture medium during cell proliferation was 
studied with radioimmunoassay. For these experiments, a lymphoblastoid cell 
line of high viability was used to avoid contamination by aI-AG originating 
from human serum and to minimize accumulation of  products from disaggregat- 
ing cells. Fig. 7 shows the increase of al-AG when determined by radioimmu- 516  LEUKOCYTE  ~I-ACID  GLYCOPROTEIN 
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FIG. 6.  Cylindrical  polyacrylamide gel pattern of  immune precipitated  radioactive  anti- 
gen obtained with anti-a1-AG antiserum from ;2SI-labeled  MLC  culture medium supple- 
mented with rabbit  preimmunization serum. 
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noassay from the culture medium. After an initial, more rapid increase, there 
was a slower accumulation. 
Cleavage with CNBr of a~-AG and of Molecules Recovered by Anti-al-AG 
Antiserum from Cells and Culture  Medium.  To prove that our anti-a~-AG 
antiserum was  monospecific for  al-AG,  we performed CNBr cleavage of the 
immunoprecipitated molecules. Purified, ~25I-labeled al-AG from urine ran on 
cylindrical gels as a single peak (Fig. 8 A). Cleavage of this protein with CNBr 
resulted in three peaks (Fig.  8 B). Cleavage of the iodinated, immunoprecipi- 
tated protein isolated from the culture medium of MLC in rabbit serum gave a 
pattern similar to that of CNBr-treated purified a~-AG (Fig.  8 C).  When the 
membrane-bound form of aI-AG was  isolated  by  immunoprecipitation from 
[3H]leucine-labeled cells and cleaved by CNBr treatment, the pattern of Fig. 
8 D was obtained. Again, the peaks of highest-molecular weights correspond to 
those of CNBr-cleaved pure a~-AG. 
Discussion 
We have purified aI-AG or orosemucoid from the urine of patients with acute 
infectious  mononucleosis.  Anti-al-AG  antiserum  and  its  F(AB)2  fragments 
reacted with normal T and B lymphocytes, T lymphoblasts, granulocytes, and 
monecytes and lymphoblastoid B-cell lines as shown by immunofluorescence. 
We were not able to find this antigen on platelets,  erythrecytes, or cultured 25 
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FIa.  8,  Cylindrical polyaerylamide gel patterns of pure 12SI-labeled a1-AG (A), its CNBr 
fragments  (B),  the  CNBr  fragments  of the  antigens precipitated  with the  anti-arAG 
antiserum from ~25I-labeled MLC culture medium (C), and [3H]leucine-labeled MLC blasts 
(D). 
normal human fibroblasts. 2 The immunofluorescence and capping experiments 
indicate  that  the  antigen  is  closely  associated  with the  lipid  bilayer  of the 
membrane (31). Surface radiolabeling of cells followed by immunoprecipitation 
and polyacrylamide gel electrophoresis revealed that the membrane form of al- 
AG has a  mol wt of 52,000.  The same molecule was obtained after metabolic 
labeling  of lymphoblasts  in  MLC  with  [3H]leucine.  On  the  other  hand,  the 
molecule isolated from the culture medium either after [aH]leucine  labeling or 
after 12~I-iodination of the medium,  had an apparent mol wt of 41,000  which 
corresponds to that  of c~I-AG in serum  and  urine.  Although the  arAG was 
detectable  on resting  T  and  B  lymphocytes  by  indirect immunofluorescence, 
sufficient radioactivity could not be introduced by surface labeling to yield a 
distinguishable band in the fluorography patterns of cells, or to allow isolation 
of significant amounts by immunoprecipitation. In the fluorography patterns of 
surface-labeled MLC T blasts and LBL (data not shown, 32), the GP 52,000 band 
was clearly  seen  and  could be  specifically recovered by the  antiserum.  This 
indicates that the ~-AG constitutes only a minor component on the surface of 
resting lymphocytes, whereas it is more abundantly expressed on activated and 
2 C.  G. Gahmberg and L. C. Andersson. Manuscript in preparation. 518  LEUKOCYTE  ~I-ACID  GLYCOPROTEIN 
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Fro. 9.  Scheme of  the cleavage points of  aI-AG with CNBr. The CNBr-sensitive rnethio- 
nine residues are at positions  110 and 156,  resulting  in peptides 2 and 1 (Fig.  8). The five 
oligosaccharide  side  chains are indicated. 
proliferating T and B cells. The 41,000 mol wt protein found in variable amounts 
on freshly isolated blood granulecytes might partially represent adsorbed serum 
al-AG. 
The difference seen in molecular weights between the membrane-bound and 
secreted molecules may be due to a  hydrophobic fragment, which anchors the 
protein to the membrane. This would thus resemble the HLA-molecules where 
the membrane-bound form apparently has a  hydrophobic intramembrane per- 
tion (33). 
The structure of soluble al-AG is well known from the studies by Schmid et 
al.  (2,  5)  and Ikenaka  et  al.  (7). It  is  rich  in  carbohydrate, containing five 
asparagine-linked oligosaccharide side chains.  The carbohydrate is all in the 
first part of the molecule, and in this respect it resembles another well-studied 
membrane glycoprotein,  the  major  sialoglycoprotein of human  erythrocytes 
(34). 
Elucidation of the primary structure of al-AG showed one constant methio- 
nine residue at position 110, and variably one more at residue 156 (5). Treatment 
with CNBr therefore results in cleavage at position 110 and in addition, in part 
of the molecules at position  156 giving large and easily distinguishable frag- 
ments. A schematic drawing of the cleavage points is shown in Fig. 9. The mo- 
lecular weights of  fragments 1 and 2 seen on the gels (Fig. 8) correspond to those 
expected from the primary structure. Fragments I and 2 both contain carbohy- 
drate, which was seen ai~r cleavage of al-AG labeled with 3H by the galactose 
oxidase method.  2 
The  antigen on  granulocytes and  monocytes with  an  apparent  mol  wt  of 
52,000  reacting with anti-al-AG antiserum had the same apparent molecular 
weight as  that  of lymphocytes. We  have not studied the molecule from the 
nonlymphoid cells as extensively as that of lymphoid cells, but it is reasonable 
to assume that they are identical or nearly similar. 
The elevated serum concentrations of aI-AG under various conditions have 
been somewhat difficult to explain by stimulation of liver synthesis alone (2). 
Inflammation, major surgery, and cancer are associated with proliferation of 
leukocytes, and at least part of the increased serum a~-AG may originate from 
such cells. 
Serum al-AG has been shown to bind different steroids (35). The cell surfaco- 
located form of a~-AG would also be expected to do it.  Steroids have profound 
effects on lymphocyte functions in  vivo and in  vitro  (36), and both T  and B 
lymphocytes contain  steroid  receptors  (37). Although  the  cytoplasmic  and CARL  G.  GAHMBERG  AND  LEIF  C.  ANDERSSON  519 
nuclear binding of steroids are well documented (38), there may also be surface- 
located receptors. 
Isoelectric  focusing  resolves  desialylated  aI-AG  from  one  individual  into 
several bands,  indicating  heterogeneity  (5).  Whether these variants of serum 
a~-AG are specific products of different types of cells or tissues remains to be 
established,  a~-AG  might  be important  for intracellular  communication  and 
recognition  by leukocytes.  Such a  role for  a~-AG is  supported  by the  recent 
findings of Chiu et al. (39) that addition of a~-AG to lymphocyte cultures altered 
the MLC response. 
Summary 
Specific antibodies against human  al-acid glycoprotein reacted with human 
lymphocytes, granulocytes, and monocytes. The antigen on the leukocytes is an 
externally located integral  membrane glycoprotein which is made by the cells 
and has an apparent mol wt of 52,000.  It is released from cells in vitro to the 
culture  medium.  The  mol wt of the  soluble fragment  is 41,000,  which corre- 
sponds  to that  of al-acid  glycoprotein in  serum  and  urine.  Peptide mapping 
confirmed that the main part of the cellular membrane antigen consists of al- 
acid  glycoprotein  with  an  additional,  probably  hydrophobic  fragment.  This 
finding  may  partially  explain  the  increase  in  the  serum  levels  of  a~-acid 
glycoprotein observed in many disorders involving leukocyte proliferation.  In 
addition,  the known sequence homology of al-acid glycoprotein with immuno- 
globulins  can  now be  more  easily understood  by their  origin  in  similar  cell 
types. 
The skillful  technical assistance of Anneli Asikainen, Maria Wilkman, and Liisa  R~iisiinen  is 
acknowledged. 
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